🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Artha Select Fund closes at Rs 432 Cr; AUM crosses Rs 1,200 Cr

EntrackrEntrackr · 2m ago
Artha Select Fund closes at Rs 432 Cr; AUM crosses Rs 1,200 Cr
Medial

Artha India Ventures (AIV) has closed its follow-on fund, Artha Select Fund (ASF), at Rs 432 crore, 131% above its Rs 330 crore target. With this, Artha’s total Assets Under Management have crossed Rs 1,200 crore. ASF will invest in the top 15% of performers from Artha’s existing portfolio of over 135 companies across Artha Venture Fund I, Artha Continuum Fund, and the soon-to-launch AVF II. The fund will write Series B and C cheques of around Rs 20 crore each, for 12–14 winners over the next four years. With 33 exits to date, Artha claims to have built a proven track record of identifying and nurturing category leaders. ASF creates a capital bridge from early-stage to growth, addressing India’s “missing middle” funding gap where many Series A–C companies stall due to limited capital and a lack of operational support. According to Artha, Indian family offices and ultra-high-net-worth individuals anchor 80% of the fund’s capital, with the remaining 20% from global LPs in Singapore, UAE, Mauritius, Hong Kong, Africa, and the U.S. Sponsor AIV has committed nearly 10% of the fund. ASF’s roster of backers includes household names such as Atul Kirloskar’s Family Office, DSP Family Office, Shahi Exports, HIRA Group, and Anikarth Ventures. “ASF allows us to stay invested in our most promising companies well into their scale-up phases,” said Anirudh A. Damani, Managing Partner of Artha Venture Fund & Artha Select Fund. “India has no shortage of promising ventures, but far too many face a capital drought between Series A and C. ASF ensures our winners have the firepower, strategic guidance, and operational backing to compete globally while preserving founder ownership and focus.” Artha, through its various funds, has backed startups such as OYO, Rapido, Purplle and Leverage Edu. Under the new fund, it has so far evaluated six companies and selected only spacetech startup Agnikul Cosmos, with an investment commitment of Rs 20–40 crore.

RPSG Capital Ventures closes Fund II at Rs 550 Cr

EntrackrEntrackr · 1y ago
RPSG Capital Ventures closes Fund II at Rs 550 Cr
Medial

Early-stage consumer venture capital fund RPSG Capital Ventures has announced the close of its latest Fund II with Rs 550 crore. The investor base for this fund is largely domestic including family offices, high net worth individuals and industry veterans from the consumer sector. Along with other repeat investors from its previous funds, RPSG group itself has doubled their initial investment as the anchor investor. RPSG Capital Ventures has invested into 16 companies till date that includes brands such as The Souled Store, Supertails, Perfora, mCaffeine, Vedix, SkinKraft, Plix, and True Elements amongst others. “With this new Fund, we’ll continue to invest into new age consumer businesses that have solid unit economics, differentiated positioning, and strong teams.” said Abhishek Goenka, partner at RPSG Capital Ventures. The fund invests in Series A rounds with first cheques of Rs 10 to Rs 40 crore in the digitally native consumer ecosystem across F&B, beauty, health and wellness, entertainment, lifestyle goods and consumer enabler categories.

ChrysCapital closes $2.2 Bn Fund X

EntrackrEntrackr · 6d ago
ChrysCapital closes $2.2 Bn Fund X
Medial

ChrysCapital has closed Fund X at $2.2 billion, the largest private equity fund raised by an India-focused firm. Fund X is a 60% increase from Fund IX of $1.35 billion, closed in 2022. The firm plans to invest the capital in established companies across consumer, healthcare, financial services, enterprise technology, and industrial sectors. ChrysCapital has now raised around $8.5 billion across ten private equity funds, a continuation vehicle, and a public markets fund since 1999. It has deployed over $5.5 billion across 110 portfolio companies and realised $7.8 billion across 80 exits with a reported 3.0x ROI. Its past investments include Intas Pharmaceuticals, Mankind Pharma, GeBBS Healthcare, Infogain, NSE, and Awfis. Fund X added over 30 new global investors, including pension funds, insurers, asset managers, and family offices from Japan, the Middle East, Southeast Asia, Europe, and the US. For the first time, ChrysCapital also raised capital from Indian institutional investors and large family offices. The fund reached its final close within six months of its first close. The firm plans to deploy Fund X over the next 3–4 years and has several transactions in progress. The strategy continues to focus on majority and minority investments in businesses with strong governance, clear growth levers, and defined exit visibility. ChrysCapital competes with PE firms active in India such as TPG, Bain Capital, KKR, Blackstone, Carlyle, Warburg Pincus, and Multiples.

Download the medial app to read full posts, comements and news.